Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 30:2020:8673087.
doi: 10.1155/2020/8673087. eCollection 2020.

Proactive and Integrated Management and Empowerment in Parkinson's Disease: Designing a New Model of Care

Affiliations

Proactive and Integrated Management and Empowerment in Parkinson's Disease: Designing a New Model of Care

Emma Tenison et al. Parkinsons Dis. .

Abstract

Parkinson's disease is the second most common neurodegenerative condition after Alzheimer's disease. The number of patients will rise dramatically due to ageing of the population and possibly also due to environmental issues. It is widely recognised that the current models of care for people with Parkinson's disease or a form of atypical parkinsonism lack continuity, are reactive to problems rather than proactive, and do not adequately support individuals to self-manage. Integrated models of care have been developed for other chronic conditions, with a range of positive effects. A multidisciplinary team of professionals in the United Kingdom and the Netherlands, all with a long history of caring for patients with movement disorders, used knowledge of deficiencies with the current model of care, an understanding of integrated care in chronic disease and the process of logic modelling, to develop a novel approach to the care of patients with Parkinson's disease. We propose a new model, termed PRIME Parkinson (Proactive and Integrated Management and Empowerment in Parkinson's Disease), which is designed to manage problems proactively, deliver integrated, multidisciplinary care, and empower patients and their carers. It has five main components: (1) personalised care management, (2) education and empowerment of patients and carers, (3) empowerment of healthcare professionals, (4) a population health approach, and (5) support of the previous four components by patient- and professional-friendly technology. Having mapped the processes required for the success of this initiative, there is now a requirement to assess its effect on health-related and quality of life outcomes as well as determining its cost-effectiveness. In the next phase of the project, we will implement PRIME Parkinson in selected areas of the United Kingdom and the Netherlands.

PubMed Disclaimer

Conflict of interest statement

Dr Emma Tenison, Dr Agnes Smink, Dr Sabi Redwood, Dr Sirwan Darweesh, Hazel Cottle, Angelika van Halteren, Ruth Hamlin, Jan Ypinga, and Dr Marten Munneke have no conflicts of interest to report.

Figures

Figure 1
Figure 1
The logic model structure used to design the intervention.
Figure 2
Figure 2
The logic model structure was applied to one of the six “problems with current care” in order to show potential strategies and activities to address the problem, the outputs/process measures, and the anticipated outcomes. This figure summarizes the content from the detailed logic model which was developed.

References

    1. GBDPsD Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurology. 2018;17(11):939–953. - PMC - PubMed
    1. de Lau L. M., Breteler M. M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525–535. doi: 10.1016/s1474-4422(06)70471-9. - DOI - PubMed
    1. Feigin V. L, Abajobir A. A., Abate K. H., et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. The Lancet Neurology. 2017;16(11):877–897. doi: 10.1016/S1474-4422(17)30299-5. - DOI - PMC - PubMed
    1. Ishihara L. S., Cheesbrough A., Brayne C., Schrag A. Estimated life expectancy of Parkinson’s patients compared with the UK population. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(12):1304–1309. doi: 10.1136/jnnp.2006.100107. - DOI - PMC - PubMed
    1. Bach J.-P., Riedel O., Klotsche J., Spottke A., Dodel R., Wittchen H.-U. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson’s disease. Journal of the Neurological Sciences. 2012;314(1-2):41–47. doi: 10.1016/j.jns.2011.11.002. - DOI - PubMed

LinkOut - more resources